Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
OprI
Description:
OprI is an outer membrane lipoprotein of Pseudomonas aeruginosa studied in bacterial membrane biology and as a vaccine antigen.
Primary topic:
Bacterial biofilms and quorum sensing (23%)
Related topics:
Bacterial biofilms and quorum sensing (23%),
Bacterial Infections and Vaccines (23%)
OpenAlex ID:
keywords/opri
Pseudomonas aeruginosa Population Structure Revisited
2009
·
Jean-Paul Pirnay
, Florence Bilocq
, et al.
·
PLoS ONE
·
349
PDF
Direct detection and identification of Pseudomonas aeruginosa in clinical samples such as skin biopsy specimens and expectorations by multiplex PCR based on two outer membrane lipoprotein genes, oprI and oprL
1997
·
D De Vos
, A Lim
, et al.
·
Journal of Clinical Microbiology
·
292
Use of Real-Time PCR with Multiple Targets To Identify Pseudomonas aeruginosa and Other Nonfermenting Gram-Negative Bacilli from Patients with Cystic Fibrosis
2003
·
Xuan Qin
, Julia Emerson
, et al.
·
Journal of Clinical Microbiology
·
177
Role of Pseudomonas aeruginosa Peptidoglycan-Associated Outer Membrane Proteins in Vesicle Formation
2012
·
Aimee K. Wessel
, Jean Liew
, et al.
·
Journal of Bacteriology
·
139
PDF
Molecular identification and detection of virulence genes among Pseudomonas aeruginosa isolated from different infectious origins.
2012
·
V S Nikbin
, M M Aslani
, et al.
·
PubMed Central
·
119
PDF
Molecular Characterization and Designing of a Novel Multiepitope Vaccine Construct Against Pseudomonas aeruginosa
2022
·
Jyotirmayee Dey
, Soumya Ranjan Mahapatra
, et al.
·
International Journal of Peptide Research and Therapeutics
·
109
PDF
Lipoprotein I, a TLR2/4 Ligand Modulates Th2-Driven Allergic Immune Responses
2005
·
Hilde Revets
, Gwenda Pynaert
, et al.
·
The Journal of Immunology
·
108
A Fusion Protein Vaccine Containing OprF Epitope 8, OprI, and Type A and B Flagellins Promotes Enhanced Clearance of Nonmucoid Pseudomonas aeruginosa
2009
·
Eric T. Weimer
, Haiping Lu
, et al.
·
Infection and Immunity
·
95
Outer Membrane Protein I of Pseudomonas aeruginosa Is a Target of Cationic Antimicrobial Peptide/Protein
2010
·
Yu-Min Lin
, Shih-Jung Wu
, et al.
·
Journal of Biological Chemistry
·
94
PDF
Probing the Protein Interaction Network of Pseudomonas aeruginosa Cells by Chemical Cross-Linking Mass Spectrometry
2015
·
Arti T. Navare
, Juan D. Chavez
, et al.
·
Structure
·
93
PDF
Recombinant OprF–OprI as a vaccine against Pseudomonas aeruginosa infections
2003
·
U Baumann
, E Mansouri
, et al.
·
Vaccine
·
93
Protection of immunocompromised mice against lethal infection with Pseudomonas aeruginosa by active or passive immunization with recombinant P. aeruginosa outer membrane protein F and outer membrane protein I fusion proteins
1995
·
B U von Specht
, B Knapp
, et al.
·
Infection and Immunity
·
84
Protective Efficacy of the Trivalent Pseudomonas aeruginosa Vaccine Candidate PcrV-OprI-Hcp1 in Murine Pneumonia and Burn Models
2017
·
Feng Yang
, Jiang Gu
, et al.
·
Scientific Reports
·
81
PDF
Safety and Immunogenicity of a Pseudomonas aeruginosa Hybrid Outer Membrane Protein F-I Vaccine in Human Volunteers
1999
·
Erfan Mansouri
, Josef Gabelsberger
, et al.
·
Infection and Immunity
·
81
Pseudomonas putidaResponse to Cadmium: Changes in Membrane and Cytosolic Proteomes
2012
·
Anna Manara
, Giovanni DalCorso
, et al.
·
Journal of Proteome Research
·
72
Pseudomonas aeruginosa outer membrane lipoprotein I gene: molecular cloning, sequence, and expression in Escherichia coli
1989
·
M Duchêne
, C Barron
, et al.
·
Journal of Bacteriology
·
69
Systemic, nasal and oral live vaccines against Pseudomonas aeruginosa: A clinical trial of immunogenicity in lower airways of human volunteers
2009
·
Dirk Bumann
, Christoph Behre
, et al.
·
Vaccine
·
64
Immunization with outer membrane proteins (OprF and OprI) and flagellin B protects mice from pulmonary infection with mucoid and nonmucoid Pseudomonas aeruginosa
2017
·
Ramadan Hassan
, Wael El-Naggar
, et al.
·
Journal of Microbiology Immunology and Infection
·
60
PDF
Protection against experimental Pseudomonas aeruginosa infection by recombinant P. aeruginosa lipoprotein I expressed in Escherichia coli
1990
·
M Finke
, M Duchêne
, et al.
·
Infection and Immunity
·
60
Clinical study to assess the immunogenicity and safety of a recombinant Pseudomonas aeruginosa OprF-OprI vaccine in burn patients
2003
·
Erfan Mansouri
, Sigrid Blome-Eberwein
, et al.
·
FEMS Immunology & Medical Microbiology
·
59
PDF
Safety and immunogenicity of an intranasal Pseudomonas aeruginosa hybrid outer membrane protein F-I vaccine in human volunteers
2001
·
M Larbig
, E Mansouri
, et al.
·
Vaccine
·
58
Mechanistic research holds promise for bacterial vaccines and phage therapies for Pseudomonas aeruginosa
2019
·
Austin Hoggarth
, Andrew Weaver
, et al.
·
Drug Design Development and Therapy
·
57
PDF
RNASeq Based Transcriptional Profiling of Pseudomonas aeruginosa PA14 after Short- and Long-Term Anoxic Cultivation in Synthetic Cystic Fibrosis Sputum Medium
2016
·
Muralidhar Tata
, Michael T. Wolfinger
, et al.
·
PLoS ONE
·
55
PDF
Identification of a 25-aminoacid sequence from the major African swine fever virus structural protein VP72 recognised by porcine cytotoxic T lymphocytes using a lipoprotein based expression system
1998
·
Alexandre Leitão
, Achut Malur
, et al.
·
Journal of Virological Methods
·
50
Evaluation of Antibiotic Resistance and Virulence Genes among Clinical Isolates of Pseudomonas aeruginosa from Cancer Patients
2020
·
Naveed Ahmed
, Zeshan Ali
, et al.
·
Asian Pacific Journal of Cancer Prevention
·
49
PDF
Show more works
View as search
Works count:
132
Citation count:
3,429
Year
Topic
Type